Lanthanum carbonate treatment of patients with hyperphosphatemia undergoing CAPD.
Kawanishi
H
H
Ishida
M
M
Ishizaki
M
M
Takuma
Y
Y
Tamura
H
H
Kobayashi
S
S
Tamura
T
T
Ohashi
H
H
Hiramatsu
M
M
Minakuchi
J
J
Hirakata
H
H
Shigematsu
T
T
D000328:Adult; D005260:Female; D006801:Humans; D054559:Hyperphosphatemia / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D007811:Lanthanum / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D010531:Peritoneal Dialysis, Continuous Ambulatory
C119467:lanthanum carbonate; D007811:Lanthanum